Clinical Biomarkers in Alpha-mannosidosis

Alpha-mannosidosis

Expanded Access to Velmanase Alfa Lamazym Aftercare Study Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients Evaluation of Long-term Efficacy of Treatment With Lamazym Clinical Biomarkers in Alpha-mannosidosis A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis Biomarker for Mannosidosis Disease (BioMannosidosis) Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis